These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37236213)

  • 1. Neisseria gonorrhoeae ciprofloxacin susceptibility testing and gyrA targets - Authors' reply.
    Rubin DHF; Mortimer TD; Grad YH
    Lancet Microbe; 2023 Aug; 4(8):e575. PubMed ID: 37236213
    [No Abstract]   [Full Text] [Related]  

  • 2. Neisseria gonorrhoeae ciprofloxacin susceptibility testing and gyrA targets.
    Tickner JA; Trembizki E; Whiley DM
    Lancet Microbe; 2023 Aug; 4(8):e574. PubMed ID: 37236216
    [No Abstract]   [Full Text] [Related]  

  • 3. Reflex Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae by Use of the SpeeDx ResistancePlus GC Assay.
    Lee DYJ; Ashcroft MM; Chow EPF; Sait M; De Petra V; Tschaepe M; Lange S; Taiaroa G; Bradshaw CS; Whiley DM; Fairley CK; Howden BP; Chen MY; Pasricha S; Williamson DA
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33658263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wild-Type Gyrase A Genotype of Neisseria gonorrhoeae Predicts In Vitro Susceptibility to Ciprofloxacin: A Systematic Review of the Literature and Meta-Analysis.
    Allan-Blitz LT; Wang X; Klausner JD
    Sex Transm Dis; 2017 May; 44(5):261-265. PubMed ID: 28407640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a Rapid Genotypic Assay to Promote Targeted Ciprofloxacin Therapy of Neisseria gonorrhoeae in a Large Health System.
    Allan-Blitz LT; Humphries RM; Hemarajata P; Bhatti A; Pandori MW; Siedner MJ; Klausner JD
    Clin Infect Dis; 2017 May; 64(9):1268-1270. PubMed ID: 28034887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study.
    Rubin DH; Mortimer TD; Grad YH
    Lancet Microbe; 2023 Apr; 4(4):e247-e254. PubMed ID: 36868257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the viasure Neisseria gonorrhoeae ciprofloxacin resistant assay for the simultaneous identification and direct detection of ciprofloxacin susceptibility.
    Sánchez NO; Pérez NF; Martínez SB
    Diagn Microbiol Infect Dis; 2022 Dec; 104(4):115798. PubMed ID: 36215941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multisite implementation of a real-time polymerase chain reaction assay to predict ciprofloxacin susceptibility in Neisseria gonorrhoeae.
    Ellis O; Hemarajata P; Shahkolahi A; Masinde G; Buchs K; Humphries RM; Klausner JD
    Diagn Microbiol Infect Dis; 2019 Jul; 94(3):213-217. PubMed ID: 30723007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance patterns (1999-2002) and characterization of ciprofloxacin-resistant Neisseria gonorrhoeae in Korea.
    Yoo J; Yoo C; Cho Y; Park H; Oh HB; Seong WK
    Sex Transm Dis; 2004 May; 31(5):305-10. PubMed ID: 15107634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Cas13a-based assays for
    Allan-Blitz L-T; Shah P; Adams G; Branda JA; Klausner JD; Goldstein R; Sabeti PC; Lemieux JE
    mSphere; 2023 Oct; 8(5):e0041623. PubMed ID: 37732792
    [No Abstract]   [Full Text] [Related]  

  • 11. Sharp increase in ciprofloxacin resistance of
    Crucitti T; Belinga S; Fonkoua MC; Abanda M; Mbanzouen W; Sokeng E; Nzouankeu A
    Int J STD AIDS; 2020 May; 31(6):579-586. PubMed ID: 32316853
    [No Abstract]   [Full Text] [Related]  

  • 12. Genotyping of two Neisseria gonorrhoeae fluroquinolone-resistant strains in the Brazilian Amazon Region.
    Ferreira WA; Ferreira CM; Naveca FG; Almeida NC; Vasconcelos Wde S; Gomes Jde S; Silva Mde F; Alecrim Md
    Mem Inst Oswaldo Cruz; 2011 Aug; 106(5):629-31. PubMed ID: 21894387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of Neisseria gonorrhoeae susceptibility to ciprofloxacin in clinical specimens from men using a real-time PCR assay.
    Magooa MP; Müller EE; Gumede L; Lewis DA
    Int J Antimicrob Agents; 2013 Jul; 42(1):63-7. PubMed ID: 23623337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of a ceftriaxone-resistant Neisseria gonorrhoeae strain found in Switzerland: a case report.
    Egli K; Roditscheff A; Flückiger U; Risch M; Risch L; Bodmer T
    Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):52. PubMed ID: 34362393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae.
    Ebeyan S; Windsor M; Bordin A; Mhango L; Erskine S; Trembizki E; Mokany E; Tan LY; Whiley D;
    J Antimicrob Chemother; 2019 Jul; 74(7):1820-1824. PubMed ID: 30897201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae.
    Roy K; Wang SA; Meltzer MI
    Emerg Infect Dis; 2005 Aug; 11(8):1265-73. PubMed ID: 16102317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection.
    Allan-Blitz LT; Hemarajata P; Humphries RM; Wynn A; Segura ER; Klausner JD
    Sex Transm Dis; 2018 Feb; 45(2):87-91. PubMed ID: 29329176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Sep; 49(37):833-7. PubMed ID: 11012233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance and heterogeneity of Neisseria gonorrhoeae isolated from patients attending sexually transmitted infection clinics in Lusaka, Zambia.
    Sarenje KL; van Zwetselaar M; Kumburu H; Sonda T; Mmbaga B; Ngalamika O; Maimbolwa MC; Siame A; Munsaka S; Kwenda G
    BMC Genomics; 2024 Mar; 25(1):290. PubMed ID: 38500064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.